NEW YORK (GenomeWeb) – Immunodiagnostic firm Singulex said today that it closed a $50 million senior secured debt facility with Perceptive Advisors. The firm plans to use the financing to continue to develop its single-molecule counting technology that detects disease-associated biomarkers.
Cantor Fitzgerald acted as exclusive financial advisor and sole placement agent to Singulex.